CSF markers for incipient Alzheimer's disease
Top Cited Papers
- 1 October 2003
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 2 (10), 605-613
- https://doi.org/10.1016/s1474-4422(03)00530-1
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- CSF tau protein and β‐amyloid (1–42) in Alzheimer's disease diagnosis: discrimination from normal ageing and other dementias in the Greek populationEuropean Journal of Neurology, 2003
- Differentiation of Geriatric Major Depression From Alzheimer’s Disease With CSF Tau Protein Phosphorylated at Threonine 231American Journal of Psychiatry, 2003
- CSF markers related to pathogenetic mechanisms in Alzheimer's diseaseJournal of Neural Transmission, 2002
- Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsyMovement Disorders, 2002
- Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study groupNeurobiology of Aging, 2002
- Cerebrospinal Fluid Amyloid β1–42 Levels in the Mild Cognitive Impairment Stage of Alzheimer's DiseaseExperimental Neurology, 2001
- Primary Degenerative Mild Cognitive Impairment: Study Population, Clinical, Brain Imaging and Biochemical FindingsDementia and Geriatric Cognitive Disorders, 2001
- Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer’s disease patientsJournal of Neural Transmission, 2001
- The Cerebrospinal Fluid Levels of Tau, Growth-Associated Protein-43 and Soluble Amyloid Precursor Protein Correlate in Alzheimer’s Disease, Reflecting a Common Pathophysiological ProcessDementia and Geriatric Cognitive Disorders, 2001
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984